US Patent Issued to RELEASE THERAPEUTICS, LES HOPITAUX UNIVERSITAIRES DE GENEVE, UNIVERSITE DE GENEVE on Oct. 27 for "Immortalized myoblast cell lines and uses thereof" (Swiss Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,429, issued on Oct. 27, was assigned to RELEASE THERAPEUTICS SA (Geneva), LES HOPITAUX UNIVERSITAIRES DE GENEVE (Geneva) and UNIVERSITE DE GENEVE (Geneva).

"Immortalized myoblast cell lines and uses thereof" was invented by Aurelien Lathuiliere (Geneva), Nicolas Mach (Collonge-Bellerive, Switzerland) and Patrick Salmon (Le Grand-Saconnex, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to immortalized human cells particularly useful for cell encapsulation therapy and methods of preparation and use thereof."

The patent was filed on Aug. 12, 2020, under Application No. 17/634,563.

*For further information, in...